Standout Papers

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a mu... 2019 2026 2021 2023 221
  1. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study (2019)
    Hiddo J.L. Heerspink, Avraham Karasik et al. The Lancet Diabetes & Endocrinology

Immediate Impact

5 by Nobel laureates 32 from Science/Nature 53 standout
Sub-graph 1 of 25

Citing Papers

Early detection of cancer
2022 StandoutScience
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
2021 Standout
1 intermediate paper

Works of Chih‐Yuan Wang being referenced

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
2019 Standout
Evaluation of a selective screening for colorectal carcinoma
1999

Author Peers

Author Last Decade Papers Cites
Chih‐Yuan Wang 1033 838 741 148 3.3k
Rosário Dominguez Crespo Hirata 395 911 810 194 3.2k
Anthony Cheung 501 686 777 109 2.9k
Arthur H. Cohen 414 1110 1308 133 5.6k
Ann M. Gronowski 565 341 536 134 3.1k
Rana S. Hoda 351 1124 575 109 3.7k
M. Oberholzer 554 819 518 116 2.8k
Iwata Ozaki 495 396 1262 110 3.6k
Chris Jackson 350 782 1359 158 6.1k
Paul Perco 346 574 1076 105 2.9k
Kyung‐Ah Kim 512 1245 645 161 3.4k

All Works

Loading papers...

Rankless by CCL
2026